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Abstract: Objective: Adolescents/Young Adults (AYAs) with a chronic illness display 
elevated risk for poor psychosocial outcomes. This has been well-documented among 
AYAs attending college, yet relatively little is known about factors that place these 
individuals at risk. Illness intrusiveness (i.e., perceived illness-induced impediments to 
engaging in routine activities) is a known predictor of negative psychosocial outcomes in 
AYAs. Illness-related stigma, an understudied concept in this population, may also be a 
key contributor to increased intrusiveness. The present study investigated the hypothesis 
that higher levels of illness-related stigma would be associated with higher levels of 
depressive and anxious symptoms in AYAs, and that this relationship will be mediated by 
illness intrusiveness. Methods: College students with a chronic illness completed 
measures of illness intrusiveness, illness-related stigma, and depressive and anxious 
symptoms. Results: A path model was estimated to test the above hypothesis. Overall, the 
model yielded good fit to the data, CFI (.99), SRMR (.02), and RMSEA (.10), and 
yielded a significantly better model fit than a model where illness-related stigma and 
illness intrusiveness were estimated as independent predictors. Stigma was significantly 
related to illness intrusiveness, and illness intrusiveness was significantly related to 
depressive and anxious symptoms. Both the stigma → intrusiveness → depression, and 
the stigma → intrusiveness → anxiety indirect paths were significant. Conclusions: 
Findings support previous research indicating relationships between stigma, illness 
intrusiveness, and negative psychosocial outcomes. Results implicate illness intrusiveness 
as a possible mediator between illness-related stigma and depressive and anxious 
symptoms in AYAs. Illness intrusiveness may be a potential mechanism by which 
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Many chronic illnesses are diagnosed in childhood, and as medical treatments improve, 
more chronically ill children are living into adulthood. As such, there is a growing need to assess 
the many unique challenges and stressors associated with coping with a chronic illness during the 
transitional period between childhood and adulthood (Abraham, Silber, & Lyon, 1999; Pfeffer, 
Pfeffer, & Hodson, 2003; Verhoof, Maurice-Stam, Heymans, Evers, & Grootenhuis, 2014). It is 
well-documented that adolescents/young adults (AYAs) with a chronic illness display an elevated 
risk for the development of maladaptive psychosocial outcomes, including depression, anxiety, 
and lower quality of life, but much less is known about how this risk develops, including those 
factors that enhance the likelihood of negative psychosocial outcomes (Bryden, Dunger, Mayou, 
Peveler, & Neil, 2003; Ferro, Gorter, & Boyle, 2015; Herts, Wallis, & Maslow, 2014; Mackner & 
Crandall, 2006; Pao & Bosk, 2011; Wilder Smith et al., 2013). This risk is likely due, in part, to 
the increased risk that the AYA age group has for adjustment difficulties in general. Factors that 
are more specific to the stress and burden of coping with a chronic illness, such as illness-related 
stigma, are also likely to play an important role (Dancey, Hutton-Young, Moye, & Devins, 2002; 
Pinquart & Shen, 2011a, 2011b; Stewart-Brown et al., 2000).  
Stigma 
Stigma is broadly defined as perceived or enacted disapproval, discrimination, or 
rejection associated with an attribute or characteristic that is different or undesirable 
(Link & Phelan, 2006). Illness-related stigma, the experience of stigma as a result of a medical 
condition, has been studied in various illness populations such as HIV and epilepsy, and has 
proven to be an especially important predictor of negative psychosocial outcomes in adults with 
chronic health conditions (Quinn & Chaudoir, 2009). Although there is a relatively large body of 
research assessing illness-related stigma in adulthood, research on younger populations is quite 
limited (Cianchetti et al., 2015; Jenerette & Brewer, 2010).  
Adolescents/Young Adults (AYAs) with Chronic Illness 
Compared to younger children or older adults with chronic illnesses, AYAs are likely to 
be particularly vulnerable to socially driven forces like illness-related stigma. Adolescence and 
young adulthood is a time of great change, and AYAs are faced with many new demands and 
situations such as navigating dating relationships, shifting peer groups, and pressure to attain 
educational/career success and assert independence as they move away from home (Arnett, 
2001). Moreover, this developmental period is critical for social network establishment, and peer 
relationships are considered to be of the utmost importance (Arnett, 2000). AYAs who are also 
suffering from a chronic medical condition must confront the additional challenges associated 
with the experience of illness-related stigma (e.g., actual or perceived negative peer evaluation), 
while simultaneously coping with stressors related to their health and medical management of 
their condition (Abraham et al., 1999; Bleyer, Barr, Ries, Whelan, & Ferrari, 2017). This added 
burden carries the potential to disrupt an AYA’s social network.  
AYAs attending college may be particularly vulnerable, as college is a time of great 
social transition and peer networks may be constantly evolving. Indeed, studies of college 
students with chronic illnesses have revealed general deficits in social support (Herts et al., 2014). 
This is problematic as deficits in social support have been linked to negative outcomes such as 
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poor adherence to medical regimens, negative psychosocial outcomes such as depression and 
anxiety, and poorer health related quality of life in multiple illness populations (e.g., cancer, 
diabetes, and inflammatory bowel disease; DiMatteo & Robin, 2004; Kemp, Griffiths, & Lovell, 
2012; Skinner, John, & Hampson, 2000; Warner et al., 2016). Indeed, research on AYAs with 
epilepsy and irritable bowel disease has demonstrated associations of stigma to decreased self-
esteem and self-efficacy, limited disclosure about illness, and social withdrawal (Cianchetti et al., 
2015; Taft, Ballou, & Keefer, 2013; Taft, Keefer, Artz, Bratten, & Jones, 2011). Further, Casillas 
and colleages (2010) have identified illness-related stigma as a substantial barrier to survivorship 
care in Latino AYA survivors of pediatric cancer. 
Illness-Related Stigma 
Although much of the early stigma research linked belonging to a stigmatized group with 
negative psychosocial outcomes, recent work has shown that there is substantial variability in 
how different people perceive and cope with stigma (Allport, 1954; Erickson, 1956; Major, 
2006). Simply belonging to a stigmatized group is not the strongest predictor of negative 
psychosocial outcomes. Instead, outcomes are highly variable based on the amount of stigma 
perceived, the saliency of the stigmatized identity to the individual, and the extent to which the 
identity is central to the individual’s self-perception (Quinn & Chaudoir). For individuals with a 
chronic illness, whose illness serves as a concealable stigmatized identity (i.e., an identity that can 
be kept hidden but still carries socially undesirable qualities) levels of perceived stigma and its’ 
impact are likely to be especially variable (Crocker, Major, & Steele, 1998; Quinn & Chaudoir, 
2009). Research in adult populations has shown that increased perceptions of illness-related 
stigma is linked to increased negative psychosocial outcomes including depression and anxiety 
(Duffy, 2005; Quinn & Chaudoir, 2009; Taft & Keefer, 2016; Vanable, Carey, Blair, & 
Littlewood, 2006). This is consistent with previous research on illness-related stigma in AYAs, 
which has indicated that although stigma is a predictor of negative psychosocial outcomes, the 
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effect and experience of stigma differs between individuals, even within the same illness group 
(Dancey et al., 2002; Jenerette & Brewer, 2010; MacLeod & Austin, 2003). These findings are 
supported by Stevelink and colleagues’ (2012) model of stigma, in which negative psychosocial 
outcomes result from an affected individual experiencing, perceiving, and anticipating negative 
social reactions (See Figure 1). These stigma experiences then lead to the internalization of 
stigma, which is evidenced by negative feelings about one’s self, transformations in one’s 
identity, and maladaptive behaviors. These manifestations of the internalized stigma are then 
theorized to lead to negative psychosocial outcomes such as depression and anxiety. 
Theoretical Model 
Given the observed variability of perceived stigma, and its relationship with negative 
psychosocial outcomes, it is important to assess possible modifiable mediators which may link 
the experience of illness-related stigma to negative psychosocial outcomes. In fact, Stevelink et 
al.’s (2012) model indicates that there are likely mediators to the effects of stigma. Specifically, 
they predict that an individual who perceives or expects stigma from others will engage in 
“maladaptive behaviors,” which can include avoiding typical activities. Illness intrusiveness, an 
established predictor of psychosocial distress in adult and AYA populations, may be an important 
construct to assess as a mediator, as it is defined as the extent to which one’s illness is believed to 
induce disruptions in lifestyle, activities, values, and interests (Devins, 2010; Mullins et al., 
2017). Illness intrusiveness is believed to negatively affect quality of life and psychosocial 
outcomes by reducing positive experiences associated with valued activities, and by decreasing 
perceived control over one’s experiences (Devins et al., 1996). Further, illness intrusiveness is 
hypothesized to result from an individual’s perception of their illness and their environment, and 
may be magnified by negative cognitions about one’s self, such as illness related-stigma (Dancey 
et al., 2002). Indeed, two previous studies have identified illness intrusiveness as a mediator 
between illness-related stigma and negative psychosocial outcomes (Dancey et al., 2002; Devins, 
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Stam, & Koopmans, 1994). Importantly, neither of these studies were in pediatric or AYA 
populations, and neither used contemporary statistical analyses. Thus, there is much to gain from 
understanding how varying levels of perceived illness-related stigma may serve as a precursor to 
the disruption of daily activities that is captured by illness intrusiveness.  
Study Aims 
To this aim, the current study seeks to evaluate the relationship of perceived illness-
related stigma and negative psychosocial outcomes of depression and anxiety in a sample of AYA 
college students. Specifically, this study aims to expand on the existing literature that has linked 
perceptions/expectations of stigma with negative psychosocial outcomes by assessing the extent 
to which illness intrusiveness serves as a mediator of this relationship. It is hypothesized that 
stigma will be associated with higher levels of illness intrusiveness. Further, it is predicted that a 
model in which illness intrusiveness is a mediator will yield better fit to the data than a model 
which assesses illness intrusiveness and stigma as independent predictors of depressive and 




REVIEW OF THE LITERATURE 
 
Adolescence and Young Adulthood 
 Typically developing adolescents and young adults (AYAs) are faced with numerous 
changes, transitions, and new experiences such as navigating dating relationships, shifting peer 
groups, pressure to perform well in school and plan for future careers, moving away from home, 
and facing their newly found independence (Arnett, 2001; Eiser, Penn, & Katz, 2009). AYAs 
experience changes in their self-perception, the roles that they serve in their environment, and 
biological changes, which can make them vulnerable to negative psychosocial outcomes (Arnett, 
2015; Orth, Robins, & Roberts, 2008; Robins, Fraley, Roberts, & Trzesniewski, 2001). Modern 
theories about the unique challenges of adolescence and young adulthood were sparked by Erik 
Erikson’s seminal work in characterizing psychosocial life stages of development. According to 
Erikson’s theory of psychological development, identity formation and social relationships are the 
two most vital areas of development during this stage (Erikson, 1956). 
 The research which has followed Erikson’s work has identified that the transition to 
adulthood is highly dependent upon culture, and the cultural expectations that exist for 
individuals of this age (Arnett, 2015; Schwartz, Zamboanga, Luyckx, Meca, & Ritchie, 2013). 
Over the past half-century, there has been a dramatic shift in cultural expectations (Bynner, 2005; 
Schwartz, Côté, & Arnett, 2005). Now, instead of quickly shifting from adolescence to adulthood
at the age of 8, the process is prolonged. The adolescence/young adulthood age is an extended 
period where individuals are no longer children, but also not quite adults, and going to college 
and postponing the initiation of careers and families has become socially normative. Currently, 
AYAs in the United States increasingly tend to place high importance on social aspects of their 
lives, such as their status compared to peers, the perception that their peers have of them, and 
their relationships with peers (Montgomery, 2005). 
This age group, coined “emerging adulthood” by many developmental psychology 
researchers, can be characterized by five elements: assertion of independence, instability, self-
focus, feeling in-between, and possibilities (Arnett, 2015). Further, research has shown that 
AYAs across ethnic groups self-identify establishing independence and forging relationships to 
be among the most important aspects of transitioning to adulthood (Arnett, 2003). Thus, 
adolescence appears to be a critical time period for establishing new peer relationships as their 
environment changes and they assert their independence, now more than ever before. Arnett and 
colleagues have argued that these five unique elements, which characterize the AYA period are 
specifically linked to mental health risks (Arnett, Žukauskienė, & Sugimura, 2014). For example, 
the instability of changing environments might put AYAs at risk for loss of various social 
supports, which would leave them more vulnerable to depression and anxiety.  
Unfortunately, despite a recent shift towards focusing more research on the AYA 
population, relatively limited research has been devoted to understanding the unique 
developmental risk for negative psychosocial outcomes at this age (Schulenberg, Sameroff, & 
Cicchetti, 2017). What is known is that AYAs are at an increased risk for developing untoward 
psychological outcomes as compared to their younger or older peers (Schulenberg & Zarrett, 
2006). A 2005 epidemiological review indicated that the 12-month prevalence of any psychiatric 
condition in individuals aged 18-29 was 40%, which was higher than for any other age range 
(Kessler et al., 2005). Importantly, the development of psychopathology during the AYA time 
period is also associated with an increased risk for life-long issues with poor psychosocial 
7 
 
outcomes (Kim-Cohen et al., 2003). Thus, the study of risk and resiliency factors in AYAs is 
critical, particularly for those who face additional stressors, such as having a chronic illness. 
Coping with Chronic Illness as an Adolescent/Young Adult  
 A chronic illness is defined as a condition which is not yet curable or is highly resistant to 
treatment and has been present for longer than three months, or will likely last longer than three 
months, or has occurred three or more times in a year and will likely reoccur (Mokkink, Van Der 
Lee, Grootenhuis, Offringa, & Heymans, 2008). Many such conditions develop during early 
childhood, and as a result of medical advancement, many children are surviving illness and aging 
into adulthood. Thus, it is imperative to understand how the stress of coping with a chronic illness 
impacts AYAs as they encounter developmental changes in the process of reaching adulthood 
(Abraham, Silber, & Lyon, 1999; Pfeffer, Pfeffer, & Hodson, 2003; Verhoof, Maurice-Stam, 
Heymans, Evers, & Grootenhuis, 2014). According to national data collected between 2011-2012, 
roughly 17.5% of youth between the ages of 12-17 years have one chronic health condition, and 
roughly 13.3% have two or more chronic conditions, indicating that almost one third of youth 
have at least one chronic condition (Child and Adolescent Health Measurement Initiative, 2012). 
Data collected by the American College Health Association indicates that among youth who go 
on to attend college, roughly 19.7% report having an allergic condition, 9.1% report having 
asthma or asthma-related illness, and 5.2% report having another chronic condition such as 
diabetes, cancer, or inflammatory bowel disease (Hoban & Leino, 2013). 
 Research specific to psychosocial outcomes of Adolescents/Young Adults (AYAs) with a 
chronic illness is relatively new, with dedicated research on this population only beginning in the 
past two decades. The emerging literature suggests that the majority of AYAs, as well as children 
and adults, who have a chronic illness appear to cope well and are thus resilient. However, there 
also appears to be a notable subset who experience significant psychological distress or 
difficulties in adjustment (Bryden, Dunger, Mayou, Peveler, & Neil, 2003; Clarke & Currie, 
2009; Pao & Bosk, 2011; Pinquart & Shen, 2011a, 2011b, 2011c). Adolescents who are coping 
8 
 
with a chronic illness are not only more likely to experience internalizing and externalizing 
symptoms than their healthy peers, but the trajectories of their psychological symptoms are also 
worse as they age into young adulthood (Ferro, Gorter, & Boyle, 2015). A series of meta-analyses 
conducted by Pinquart and Shen (2011) found small but significant effect sizes when comparing 
levels of depressive symptoms, anxious symptoms, and behavior problems of healthy adolescents 
with their chronically ill peers. Additionally, Pinquart and Shen found that larger effect sizes 
existed for studies with more girls than boys, which suggests that female AYAs may be at 
particular risk for psychological distress.  
Given the unique risk associated with the AYA age range (see section 
Adolescence/Young Adulthood), it is thus likely that AYAs coping with a chronic illness are 
uniquely vulnerable to negative psychosocial outcomes. Additionally, the presence of negative 
psychosocial outcomes may be especially concerning as the development of psychopathology at 
this age is associated with long-term psychosocial risk (Hampel, Rudolph, Stachow, Laß-
Lentzsch, & Petermann, 2005). As mentioned previously, adolescence and young adulthood is a 
time that is accompanied by many new stressors and challenges such as gaining independence, 
dating, and moving away from home. AYAs with a chronic illness must tackle each of these 
challenges in addition to many illness-specific stressors, such as adhering to treatment protocols 
(e.g., taking medication, monitoring physiological data such as glucose, dietary restrictions), 
attending doctor visits, and learning to manage their own care. The compounded stress of coping 
with typical stressors faced by AYAs, in addition to illness-specific stressors, may contribute to 
the elevated psychosocial distress that is seen in this population (Abraham et al., 1999; Bleyer, 
Barr, Ries, Whelan, & Ferrari, 2017). Further, the psychological distress potentially experienced 
by an AYA with a chronic illness during this vital time for social development may be harmful to 
AYAs’ ability to successfully meet developmental milestones. For instance, depression is 
associated with social withdrawal and lack of interest. Such symptoms may inhibit AYAs from 
engaging with peers and forging intimate peer relationships (Rubin, Coplan, & Bowker, 2009). 
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For AYAs with a chronic illness, social withdrawal as a result of depressive symptoms may be 
especially harmful as social support has been shown to be an important contributor to resiliency 
among AYAs coping with chronic illness.  
Deficits in social support and lack of social engagement have indeed been linked to more 
anxious and depressive symptoms in AYAs, and are also related to poorer adherence to medical 
regimens and reduced health-related quality of life (DiMatteo & Robin, 2004; Skinner, John, & 
Hampson, 2000; Warner et al., 2016). Specifically, DiMatteo and colleagues’ (2004) meta-
analysis uncovered substantial effect sizes between social support and adherence to medical 
regimens, with the largest effects on adherence being from familial social support. Research has 
also shown that psychological distress is associated with poorer adherence to treatment protocols, 
which are vitally important to medical health outcomes (Rapoff, 2010). Research on samples of 
youth with inflammatory bowel disease, asthma, HIV, and diabetes have demonstrated that a link 
exists between anxious and depressive symptoms and adherence (Bender, 2006; Gonzalez et al., 
2008; Gray, Denson, Baldassano, & Hommel, 2012; Murphy et al., 2005; Williams et al., 2006). 
Grey and colleagues’ (2012) analyses even indicated that the link between barriers to adherence 
and adherence itself was mediated by psychological distress, indicating the importance of 
psychosocial outcomes on medical outcomes such as treatment adherence. Thus, the presence of 
psychological distress in individuals with chronic illness at this sensitive time in development 
should be considered distinctly concerning.  
In sum, AYAs with a chronic illness show an increased vulnerability for developing 
negative psychosocial outcomes as compared to their healthy peers, and they are more likely than 
healthy peers to have escalating trajectories of distress as they age into adulthood. Additionally, 
AYAs with a chronic illness who experience negative psychosocial outcomes are less likely to 
adhere to their medical regimens and are thus at an increased risk for adverse physical health 
risks, increased disease severity and course, and mortality. Thus, AYAs with a chronic illness are 
an especially vulnerable population and increased research attention to understanding risk factors 
10 
 
for developing negative psychosocial outcomes is greatly needed. One such risk factor is that of 
illness-related stigma, a construct that has been understudied in this population, but for which a 
great deal of evidence exists in the adult illness literature (Stevelink, Wu, Voorend, & van Brakel, 
2012).  
Illness-Related Stigma  
Illness-Related Stigma Framework 
 Stigma is defined as the disapproval, discrimination, or rejection associated with a 
socially undesirable trait or characteristic (Link & Phelan, 2006). Stigma can be either enacted 
(i.e., a person’s actions are directly motivated by, and displaying, disapproval, rejection, or 
discrimination towards another individual) or perceived (i.e., an individual suspects that a person 
is disapproving, discriminating, or rejecting of an individual). Although stigma is typically 
thought of in reference to traditionally observable traits such as ethnicity or gender, there is 
considerable research to suggest that individuals with chronic medical conditions are also subject 
to stigma. Individuals with chronic medical conditions possess concealable stigmatized identities, 
identities which can be hidden, but still possess socially undesirable characteristics (Crocker, 
Major, & Steele, 1998; Quinn & Chaudoir, 2009). It has historically been thought that due to the 
lack of inherent visibility, there may be some benefits to having a concealable stigmatized 
identity, such as better psychosocial outcomes (Allport, 1954; Erikson, 1956). However, research 
has indicated that the visibility or type of stigmatized group that an individual belongs to is not 
necessarily the most important predictor of psychological distress. Rather, the strongest predictors 
of psychosocial outcomes in individuals with stigmatized conditions are the extent to which an 
individual perceives others to view their trait or characteristic with stigma, the extent to which the 
stigmatized identity is salient to the individual, and the extent to which the stigmatized identity is 
central to the individual’s view of themselves (Major, 2006). Thus, individuals with concealable 
stigmatized identities in the context of a chronic illness, are believed to have variable levels of 
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psychological distress, as the experience of stigma appears to be vastly different across 
individuals.  
 Given the concealability of chronic medical conditions, individuals have the option to 
disclose their illness to others or keep it hidden. However, the option to disclose comes with its 
own sources of stress. According to a model proposed by Joachim & Acorn (2000), individuals 
with concealable stigmatized identities face a great deal of stress even if they do not disclose their 
illness to others. This is because the stress of hiding their condition and attempting to be “normal” 
may present a great number of challenges. These individuals will also experience additional stress 
and stigma if they are “caught in the lie” of pretending to be without an illness. Research also 
shows that when individuals with a concealable stigmatized identity attempt to conceal their 
condition, they report lower levels of belongingness and their peers actually rate them as having 
poorer social skills in social interactions (Newheiser & Barreto, 2014). Interestingly, studies 
reveal that over half of individuals with chronic illness prefer not to disclose their illness or prefer 
to disclose their illness to very few people (Herts, Wallis, & Maslow, 2014; Newheiser & 
Barreto, 2014).  
To understand the processes by which stigma may relate to negative psychosocial 
outcomes in adults with chronic health conditions, Stevelink and colleagues (2012) outlined a 
model based on the findings of Livingston & Boyd’s (2010) meta-analysis of mental illness-
related stigma. According to this model, individuals with chronic illness perceive stigma through 
experiencing negative social interactions, perceiving negative social interactions, and expecting 
negative social interactions. These perceptions of stigma then result in internalized stigma (i.e., 
negative perceptions about one’s own illness and own worth as a result of their condition), which 
drives negative feelings about one’s self, identity transformation, and maladaptive behaviors. 
These negative feelings, identity transformation, and maladaptive behaviors are then proposed to 
lead to negative psychosocial outcome variables such as psychological distress, guilt, shame, 
embarrassment, exclusion, isolation, withdrawal, and others. In Livingston & Boyd’s (2010) 
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meta-analysis, internalized stigma was associated not only with negative psychosocial outcomes 
but also with poorer treatment adherence. Support for Stevelink and colleagues’ (2012) model 
comes from reviews of other adult illness populations (Link & Phelan, 2001; Logie & Gadalla, 
2009; Mak, Poon, Pun, & Cheung, 2007; Van Brakel, 2006). 
Illness-Related Stigma in Adult Populations 
 Illness-related stigma has been studied for the most part in adult populations, with a great 
deal of literature specifically focusing on the stigma experiences of adults with HIV/AIDS, 
epilepsy, tuberculosis, and mental disorders (Bharat, 2011; Juniarti & Evans, 2011; Van Brakel, 
2006; Weiss, Ramakrishna, & Somma, 2006). Indeed, much of the emphasis on stigma in the 
context of chronic medical conditions began with research involving the HIV/AIDS population 
(Mahajan et al., 2008). The treatment and prevention of HIV/AIDS presented a unique challenge 
to healthcare providers as the stigma surrounding the disease was immense. The effects of this 
stigma led affected individuals to either attempt to hide or deny their illness, or else be shunned 
and ostracized. Further, the stigma associated with possibly being HIV positive left people in fear 
of getting tested, delaying their access to treatment and allowing the further spread of disease. 
Since the AIDS epidemic began in 1981, a great deal of progress has been made to reduce stigma, 
and improve access to healthcare, screenings, and prevention efforts (Mahajan et al., 2008).  
Overall, research on individuals with chronic illnesses such as HIV/AIDS, epilepsy, 
tuberculosis, cancer, diabetes, and inflammatory bowel disease has demonstrated that a 
substantial subset of individuals with these concealable stigmatized medical conditions report 
mild, moderate, or severe perceptions of stigma from their environment which ranges from 
perceiving that others view their illness as unappealing, to perceiving that others actively shun or 
reject them as a result of their illness (Chapple, Ziebland, & McPherson, 2004; Weiss et al., 
2006). Further, research consistently shows that the degree of stigma perceived is linked to 
psychosocial outcomes, such that those who experience higher levels of perceived stigma display 
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poorer psychosocial outcomes such as depression, anxiety, or global psychological distress 
(Duffy, 2005; Quinn & Chaudoir, 2009; Taft & Keefer, 2016; Vanable, Carey, Blair, & 
Littlewood, 2006). In a qualitative study examining stigma perceived by individuals with type 2 
diabetes, individuals often endorsed feeling “blamed by others for causing their own condition,” 
“being subject to negative stereotyping,” and “being discriminated against or having restricted 
opportunities in life” (Browne, Ventura, Mosely, & Speight, 2013). Further, these individuals 
identified that the stigma that they perceived came from not only cultural sources such as the 
media, but also their family, friends, colleagues, and even healthcare professionals. Browne and 
colleagues (2013) also reported that the individuals in the study reported themes of experiencing 
significant psychological distress in relation to the stigma that they perceived.  
The stigma associated with chronic medical conditions can also present physical health 
risks for those affected. Researchers have found that chronic stress, which can be the result of 
chronic stigmatization, can cause additional medical problems (Kumari, Ram, Haque Nizamie, & 
Goyal, 2009; Link & Phelan, 2006; Pascoe & Smart Richman, 2009; Taft & Keefer, 2016). This 
can include increased risk for high blood pressure, cardiovascular disease, respiratory conditions, 
diabetes, and obesity. Thus, the stress of stigma may be especially damaging as it is associated 
with additional stress-related health problems, which may worsen the course of the original 
condition. Research on individuals with inflammatory bowel disease has also demonstrated that 
not only is perceived stigma associated with negative psychosocial outcomes, but is also 
associated with decreased health-related quality of life, suggesting that there is a notable 
association between stigma and health (Taft, Ballou, & Keefer, 2013; Taft, Keefer, Artz, Bratten, 
& Jones, 2011). Further, in cases where individuals perceive a particularly high level of stigma, 
individuals may avoid or postpone medical treatment, which may also impact health outcomes 
(Duffy, 2005; Pascoe & Smart Richman, 2009). 
Findings which suggest a link between stigma and negative outcomes such as 
psychological distress and reduced quality of life are consistent throughout the literature. 
14 
 
However, recent research has also begun exploring resiliency factors associated with stigma. Taft 
and colleagues (2013) assessed the impact of stigma internalization, the extent to which a person 
believes the negative stigmatizing thoughts about themselves and their condition in a cohort of 
individuals with inflammatory bowel disease. They found that almost 40% of their sample 
experienced internalized stigma and that this stigma was significantly related to poorer 
psychosocial outcomes and health-related quality of life. However, they also found that almost 
90% of their sample endorsed stigma-resistant thoughts and behaviors, such as thinking “living 
with IBD has made me a tough survivor.” Taft and colleagues found that stigma resistance served 
as a protective factor against stigma and was associated with better psychosocial outcomes. Such 
findings suggest that individuals with chronic illness may be able to develop a positive view of 
their illness, and that this positive perception is related to better psychosocial outcomes, thus 
shedding light on possible areas for intervention. Stigma resistance as a construct has also been 
studied in populations of individuals with schizophrenia and HIV/AIDS, showing similarly 
promising results (Poindexter & Shippy, 2010; Sibitz, Unger, Woppmann, Zidek, & Amering, 
2011).  
Illness-Related Stigma in Pediatric and Adolescents/Young Adults Populations 
Although there is considerable research on illness-related stigma in adults, there is a 
relatively limited amount of research in AYA or even pediatric populations (Cianchetti et al., 
2015; Jenerette & Brewer, 2010). To date, stigma has been studied in pediatric and AYA 
populations such as epilepsy, sickle cell disease, cancer, facial differences, and mental disorders 
(Austin, MacLeod, Dunn, Shen, & Perkins, 2004; Casillas, Kahn, Doose, Landier, & Bhatia, 
2010; Elkington et al., 2012; Funderburk, McCormick, & Austin, 2007; Herts et al., 2014; 
Jacoby, 2002; Jenerette & Brewer, 2010; MacLeod & Austin, 2003; Masnari et al., 2013). Among 
these studies, those which assessed psychosocial outcomes (i.e., Austin et al., 2004; Funderburk, 
Mccormick, & Austin, 2007; Jenerette & Brewer, 2010; Masnari et al., 2013), found a link 
between perceived stigma and psychological distress. A small number of pediatric and AYA 
15 
 
studies have also assessed health-related quality of life in relation to illness-related stigma. Herts 
et al. (2014) found stigma to be negatively associated with health-related quality of life, as did 
MacLeod and Austin’s (2003) review of the pediatric epilepsy literature. Casillas and colleagues 
(2010) also identified illness-related stigma as a barrier to receiving survivorship care in young 
adults who experienced pediatric cancer, further emphasizing the risk that illness-related stigma 
has on health. 
In general, the experience of illness-related stigma appears to be similar in a number of 
ways for children/AYAs and adults with chronic health conditions. Specifically, the pediatric and 
AYA studies of illness-related stigma found that simply belonging to a stigmatized group did not 
mean that individuals invariably perceived stigma, rather, levels of stigma reported were variable 
within individuals of the same illness group. Funderburk, McCormick, and Austin (2007) found 
that children who perceived elevated levels of illness-related stigma also held negative attitudes 
toward their condition, suggesting that pediatric populations may be at risk for the internalized 
stigma that is seen in adult populations.  
According to the adult literature, individuals who feel stigmatized tend not to disclose 
their illness (Joachim & Acorn, 2000). Among pediatric and AYA studies, a number have also 
found that many or most children and AYAs prefer not to disclose their illness to others. Studies 
of children with epilepsy found that children preferred to keep their epilepsy a secret, such that 
almost 60% of children reported concealing their condition from others and 70% reported rarely 
or never talking about their epilepsy with others (Austin et al., 2004; MacLeod & Austin, 2003). 
A qualitative study of children with IBD found similar patterns of preference towards non-
disclosure (Barned, Stinzi, Mack, & O’Doherty, 2016). Additionally, Herts and colleagues (2014) 
found that among college freshmen with chronic illness, roughly half report having disclosed 
their condition to less than five of their peers. According to Jenerette and Brewer (2010), children 
with epilepsy reported that they were anxious about disclosure because of the possibility of 
negative peer evaluation associated with being different. 
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 In sum, illness-related stigma has garnered research support in adults with chronic illness 
since the AIDS epidemic in the early 1980s. Illness-related stigma has shown to have detrimental 
effects on the psychological and physical health of adults coping with chronic illness. Indeed, the 
limited research which does exist in pediatric and AYA populations indicates that the experience 
of illness-related stigma in childhood, adolescence, and young adulthood may be similar to the 
experience in adulthood. However, due to important developmental differences among these 
different age ranges, there are likely many distinctive differences between pediatric/AYA and 
adult illness-related stigma which have yet to be uncovered. Additionally, it is important to 
understand the paths by which stigma may affect negative psychosocial outcomes. As such, an 
established predictor of psychological distress in both adult and AYA populations, illness 
intrusiveness, may be an important variable to assess in relation to stigma. Illness intrusiveness is 
hypothesized to result from an individual’s perceptions about their illness, environment, and 
situation, and thus may be greatly affected by an individual’s perception of stigma from their 
peers.  
Illness Intrusiveness 
 Illness intrusiveness is defined as the extent to which an individual perceives their daily 
or valued life activities to be disrupted as a result of illness (Devins, 2010). According to the 
theory of illness intrusiveness, the disruption created by illness is associated with negative 
psychosocial outcomes by two pathways: 1) the disruption reduces or eliminates positive 
reinforcement that would be achieved by participating in a valued activity, and 2) the disruption 
reduces feelings of control over one’s life and activities (e.g., Devins, 1994, 2010). The study of 
illness intrusiveness has roots in adult populations with chronic illness and disability (Devins et 
al., 1996). This research largely indicates that illness intrusiveness is robustly associated with 
negative psychosocial outcomes such as depression and anxiety, as well as related outcomes such 
as physical health, fatigue, and marital satisfaction (e.g., Devins, 2010; Mullins et al., 2001; 
Shawaryn, Schiaffino, LaRocca, & Johnston, 2002).  
17 
 
Studies in pediatric populations have found that children who report greater illness 
intrusiveness also indicate poorer psychosocial outcomes (Wagner et al., 2003). Carpentier, 
Mullins, and Van Pelt (2007) found that, among college students with asthma, illness 
intrusiveness significantly predicted depressive and anxious symptoms as well as missed school 
days. A recent study of AYAs in college similarly found that illness intrusiveness was a 
significant predictor of depression and anxiety (Mullins et al., 2017). Additionally, in a study of 
young and middle-aged adults with ulcerative colitis, Maunder and colleagues (2007), found that 
younger age and single marital status were both risk factors for experiencing elevated levels of 
illness intrusiveness, indicating that AYAs may be at an elevated risk for illness intrusiveness.  
 Research has also shown illness intrusiveness to be associated with disease severity, 
symptom severity, treatment side effect severity, and variability of treatment regimens (Devins, 
2010). However, illness intrusiveness is believed to primarily result from an individual’s 
subjective response to and appraisal of their illness, treatment, and environment. It is believed to 
be more associated with cognitive appraisals of one’s illness than objective data about one’s 
illness and treatment. This is consistent with the majority of literature on psychosocial outcomes 
in illness populations, suggesting that objective data about illness factors is consistently less 
predictive of psychosocial outcomes as compared to cognitive appraisal variables such as illness 
intrusiveness or others like illness uncertainty (Szulczewski, Mullins, Bidwell, Eddington, & Pai, 
2017).  
To date, illness intrusiveness has been implicated as a mediating mechanism between 
stigma and negative psychosocial outcomes in at least two previous studies. Devins, Henderikus, 
and Koopmans (1994) found that, in adult patients who had recently received a laryngectomy, 
illness intrusiveness served as a mediator between perceived illness-related stigma and negative 
psychosocial outcomes. Dancey and colleagues (2002) similarly found illness intrusiveness to 
mediate the relationship between perceived illness-related stigma and quality of life in adults with 
irritable bowel syndrome. Importantly, neither of these studies assessed this mediational 
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relationship using contemporary statistical analyses of mediation, nor was this relationship 
assessed in a pediatric or AYA population.  
Summary 
 In sum, adolescents and young adults (AYA) are at an elevated risk for negative 
psychosocial outcomes such as depression and anxiety. This is likely due to the transitional nature 
of adolescence and young adulthood, as well as the many biological and social factors associated 
with this developmental stage. AYAs who are coping with additional stressors, such as chronic 
illness, are likely to be at an increased risk for negative psychosocial outcomes. Adolescence and 
young adulthood is a time for transition in many domains; however, social transitions and social 
changes seem to be of vital importance for AYAs. Thus, the stress of coping with a chronic 
condition, and the stigma which may be associated with it, may carry the potential to disrupt 
typical social development.  
 Stigma, specifically, has been identified as an important predictor on negative 
psychosocial outcomes in adults with chronic illness. Further, a small, but growing, number of 
studies have assessed illness-related stigma in pediatric and AYA populations. Such studies have 
similarly found stigma to be an important predictor of negative psychosocial outcomes. 
Frameworks for understanding stigma in adult populations have identified a number of important 
mediators in the relationship between stigma and negative psychosocial outcomes, which include: 
negative feelings about one’s self, identity transformation, and maladaptive behaviors.  
Illness intrusiveness, the extent to which an individual perceived their illness to keep 
them from engaging in daily or valued activities, may be an important mediator to assess in AYA 
illness populations. Illness intrusiveness has consistently been linked to negative psychosocial 
outcomes. Illness intrusiveness may serve as a maladaptive mechanism, such that individuals who 
perceive more stigma may be less likely to engage in daily or valued activities as a result of their 
anticipation or fear of stigma from others when engaging in such activities.   
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Presently two vital gaps exist in the illness-related stigma literature. First, stigma is 
understudied in AYAs, a group for which stigma may be especially notable. Second, while illness 
intrusiveness has been speculated to mediate the relationship between illness-related stigma and 
psychosocial outcomes, no study has yet assessed this relationship using modern statistical 
techniques. The study proposed here will serve to better define the effects of stigma in 
populations of AYAs with chronic illness. Further, the proposed study will use modern statistical 
techniques to assess the extent to which illness intrusiveness may mediate the relationship 







 Participants were collected as part of an ongoing study assessing psychosocial 
functioning in college students with and without a chronic illness. All participants were recruited 
from a large Midwestern university. Participants who completed the survey of questionnaires via 
an online portal were compensated with course credit, a requirement for many undergraduate 
courses, including psychology courses. To be included in this study, participants must have a self-
reported chronic illness (e.g., diabetes, asthma, inflammatory bowel disease), be between the ages 
of 18-24 years, and be presently enrolled as an undergraduate student. Participants were not 
excluded if they reported a chronic psychiatric condition (e.g., major depressive disorder, 
attention deficit/hyperactivity disorder), but participants must have reported at least one chronic 
illness which was not psychiatric in nature.  
Measures 
Demographic characteristics.  
Demographic information collected includes age, sex, ethnicity, education level, and type 
of chronic illness.  
Perceived severity and controllability of illness. 
Participants rated perceived severity and controllability of their illness on single-item 7-
point Likert scales ranging from “mild” to “very severe” and “entirely uncontrollable” to 
“entirely controllable”, respectively.  
Stigma Scale-Revised (SS-R) 
 The Stigma Scale-Revised (SS-R) is an 8-item self-report questionnaire which assesses 
perceived illness-related stigma on a 5-point Likert scale, with higher scores indicating more 
perceptions of stigma (Austin, 2004). The SS-R is a revised version of Austin’s (2004) Stigma 
Scale (SS), which was initially designed to assess perceived stigma related to an individual’s 
epilepsy. The SS-R used in the present study is an adapted version of the measure assessing 
perceived illness-related stigma related to an individual’s “chronic illness.” The scale asks about 
the extent to which individuals feel that others will be uncomfortable around them because of 
their chronic illness, how much others will view them differently, and how often they disclose 
their condition to others. Previous research indicates that the SS has good internal consistency (α 
= .81; Austin, MacLeod, Dunn, Shen, & Perkins, 2004). In the present study, internal consistency 
was excellent (α = .94).  
Illness Intrusiveness Rating Scale (IIRS) 
 The Illness Intrusiveness Rating Scale (IIRS) is a 13-item self-report measure assessing 
the extent to which one’s illness interferes with one’s ability to carry out daily life activities such 
as work, maintaining relationships, and involvement in the community (Devins, 1983). The items 
are on a 7-point Likert scale, with higher scores indicating higher levels of illness intrusiveness. 
Previous research indicates that the IIRS has good to high internal consistency (α = .81-.97; 
Devins, 2010). In the present study, internal consistency was excellent (α = .92).  
Center for Epidemiological Studies – Depression Scale (CES-D) 
 The Center for Epidemiological Studies – Depression Scale (CES-D) is a 20-item self-
report measure assessing current depressive symptoms on a 4-point Likert scale (Radloff, 1977). 
The items ask about domains of depression such as sadness, loss of interest, loss of appetite, 
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difficulties sleeping, difficulty thinking/concentrating, guilt, tiredness, and movement. Higher 
scores on the scale indicate higher levels of depressive symptomatology. Scores of 16 or more are 
considered to be clinically concerning (Lewinsohn, Seeley, Roberts, & Allen, 1997). Previous 
research indicates that the CES-D has good internal consistency (α = .85-.90; Radloff, 1977). In 
the present study, internal consistency was excellent (α = .95).  
Zung Self-Rating Anxiety Scale (SAS) 
 The Zung Self-Rating Anxiety Scale (SAS) is a 20-item self-report measure assessing 
current anxiety symptoms on a 4-point Likert scale (Zung, 1971). The items reflect domains of 
anxiety such as worry, physiological sensations, and nervousness. Higher scores on the scale 
indicate higher levels of anxiety symptoms. Scores of 36 or more are considered to be clinically 
concerning (Zung, 1971). Previous research indicates that the SAS has good internal consistency 
(α = .81; Olatunji, Deacon, Abramowitz, & Tolin, 2006). In the present study, internal 
consistency was good (α = .89).  
Overview of Analyses 
 Bivariate correlations initially were conducted to assess the presence of relationships 
between  variables. Path analysis, a specific type of structural equation modeling (SEM), using 
Mplus version 7.4, was used to test the relationship between illness-related stigma and both 
depressive and anxious symptoms, through illness intrusiveness as a mediator. Full information 
maximum likelihood was used to handle missing data (Ender, 2010). Stigma was entered as an 
exogenous variable, and illness intrusiveness, depression, and anxiety were entered as 
endogenous variables. Demographics were estimated for all endogenous variables, including: age, 
sex, education level, and ethnicity, which was dichotomized due to sample size. Additionally, to 
control for illness-related factors, self-reported controllability and severity of one’s illness were 
estimated on all endogenous variables. The model was evaluated by model indicators including 
the chi-square fit to the data, CFI, TLI, RMSEA, and SRMR. The indirect paths of stigma → 
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intrusiveness → depression and stigma → intrusiveness → anxiety were evaluated, with 
significant results being indirect paths with p < .05.  
An additional, alternative model was tested where stigma and illness intrusiveness were 
put in the model as independent predictors of depression and anxiety, such that no mediational 
path was tested. This model was compared to the mediational model using the Akaike and 
Bayesian criteria to test comparative model fit, to identify if the mediational model provides 
superior model fit to the alternative model (Posada, Buckley, & Thorne, 2004). Lower scores on 
the Akaike and Bayesian criteria indicate better model fit to the data.  
The presently tested mediational model contains 10 manifest variables and 28 freely 
estimated parameters. Recommendations by Bentler and Chou (1987) suggest that to have 
adequate power to detect an effect, between 5-10 cases are needed per parameter. Thus, the 







Descriptive Statistics  
Of the 285 college students who completed the study, 275 completed all four measures of 
interests, and thus were included in the present analyses. Participants in the sample were 
predominantly Caucasian (77.5%), female (76.5%), and freshmen in college (50.2%). All 
descriptive statistics are reported in Table 1. On average, participants reported their illness to be 
between moderate and severe (M = 3.99, SD = 2.15) and between mostly controllable and 
somewhat uncontrollable (M = 4.23, SD = 1.66). Participants reported significant distress, with 
43.2% reporting depressive symptoms above the clinically-concerning cut-off, and 68.4% 
reporting anxious symptoms above the clinically concerning cut-off. Depressive and anxious 
symptoms were significantly correlated (r = .80, p < .001), and 53.7% of those reporting 
clinically concerning depressive symptoms also reported clinically concerning anxious 
symptoms. Means and standard deviations of variables of interest can be found in Table 2.  
Preliminary Analyses 
Bivariate correlations revealed significant relationships between demographic and 
endogenous variables, including sex and anxiety (r = .20, p < .01) and grade level and depression 
(r = -.12, p < .05). Significant relationships were found between severity of illness and both  
stigma (r = .13, p < .05) and illness intrusiveness (r = .18, p < .001), but not depression or anxiety. 
Significant relationships were found between controllability of illness and stigma (r = -.21, p <  
.01), illness intrusiveness (r = -.26 p < .001), depression (r = -.16, p < .01), and anxiety (r = -.23, p 
< .001). Stigma, illness intrusiveness, depression, and anxiety were all significantly correlated 
with each other (ps < .001). The full correlation matrix can be found in Table 3.  
Path Analysis 
 Path analysis was used to test the mediational model with 10 manifest variables and 28 
freely estimated parameters. Demographic variables including age, sex, education level, and 
ethnicity were estimated on all endogenous variables. The model was bootstrapped to 5000. The 
estimated model yielded good fit to the data as indicated by the CFI (.99), SRMR (.02), and 
RMSEA (.10). The chi-square test of model fit yielded significant results (χ2 (2) = 8.0, p < .05), 
suggesting sub-optimal model fit, and the TLI did not meet acceptable levels (>.90) of model fit 
(TLI = .88). However, there is evidence to suggest that the chi-square test is not the best indicator 
of model fit as it is often significant in sample sizes greater than 200, and the TLI is simply a 
transformation of the chi-squared (Hooper, Coughlan, & Mullen, 2008). Thus, it is believed that 
the model fit is still good. All anticipated direct paths were significant. Stigma was significantly 
related to illness intrusiveness (B = 1.18, SE = .09, p < .001). Illness intrusiveness was 
significantly related to both depressive (B = .43, SE = .05, p < .001) and anxious symptoms (B = 
.37, SE = .03, p < .001). Thus, higher perceptions of stigma were related to more illness 
intrusiveness, which, in turn, were related to increased depressive and anxious symptoms. 
Further, the indirect paths between stigma and both depression (B = .50, SE = .07, p < .001) and 
anxiety (B = .44, SE = .05, p < .001) were significant, indicating that illness intrusiveness was a 
significant mediator of the relationship. Akaike and Bayesian comparative fit indices were AIC = 
6128.95, BIC = 6230.22. Overall, this model accounted for 44% of the variance in illness 
intrusiveness, 40% of the variance in anxious symptoms, and 29% of the variance in depressive 
symptoms. See Figure 2 for a depiction of the mediational model. 
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 The alternative path model was estimated with 10 manifest variables and 29 freely 
estimated parameters. Demographic variables including age, sex, education level, and ethnicity 
were estimated on all endogenous variables. The model was bootstrapped to 5000. The estimated 
model yielded significantly poorer fit to the data, with the Akaike (AIC = 6246.49) and Bayesian 
(BIC = 6351.38) comparative fit indices indicating poorer model fit as compared to the 
mediational model. As such, the model in which illness intrusiveness was considered as a 
mediator yielded improved fit to the data as compared to the model in which stigma and illness 







The present study examined the relationships between illness-related stigma, illness 
intrusiveness, and depressive and anxious symptoms in a population of college student AYAs. 
These results align with previous findings which suggest both illness-related stigma and illness 
intrusiveness to be important predictors of negative psychosocial outcomes (i.e., depression and 
anxiety; Devins, 2010; MacLeod & Austin, 2003). Importantly, while a small number of studies 
have assessed the relationship between illness-related stigma and negative psychosocial outcomes 
in pediatric populations (e.g., Austin, MacLeod, Dunn, Shen, & Perkins, 2004; Funderburk, 
McCormick, & Austin, 2007; Masnari et al., 2013), illness-related stigma is a novel predictor in 
AYA illness populations. The present study is the first known to assess the relationship between 
illness-related stigma and negative psychosocial outcomes in an AYA population, with previous 
pediatric studies assessing children only up until the age of 16 (Austin et al., 2004; Funderburk et 
al., 2007; Masnari et al., 2013). To build upon this previous research, the present study also 
sought to theoretically understand how illness-related stigma may lead to these negative 
psychosocial outcomes. According to Stevelink and colleagues’ (2012) model, which is specific 
to illness-related stigma in adults, the primary means by which illness-related stigma affects 
psychosocial outcomes is through behavioral manifestations, including maladaptive behaviors 
and cognitions. Thus, the present study sought to test illness intrusiveness as a possible 
behavioral mechanism by which illness-related stigma may influence psychosocial outcomes.  
Illness intrusiveness has been widely implicated as a contributor towards negative 
psychosocial outcomes in pediatric, adult, and AYA populations, and across a range of illness 
populations (Devins, 2010). Most recently, Mullins and colleagues (2017) conducted a related 
study of college student AYAs, finding that illness intrusiveness was a particularly important 
predictor of both depressive and anxious symptoms, even when controlling for self-reported 
severity and controllability of illness. The current findings further identified illness intrusiveness 
as a significant mediator between illness-related stigma and both depressive and anxious 
symptoms. Importantly, comparative model fit analyses revealed that the model assessing illness 
intrusiveness as a mediator yielded better fit to the data than a model in which illness-related 
stigma and illness intrusiveness were considered as independent predictors. Thus, our results 
support previous studies which have identified illness-related stigma as a mediator between 
illness-related stigma and negative psychosocial outcomes (Dancey et al., 2002; Devins et al., 
1994). Yet, the present study adds considerably to our understanding of this relationship, as 
previous studies which have assessed these constructs together were tested only in adult 
populations, and in limited illness populations (i.e., laryngectomy and irritable bowel syndrome).  
Most studies of illness intrusiveness have evaluated the construct as an independent 
predictor of negative psychosocial outcomes (Devins, 2010). However, we tested the importance 
of illness intrusiveness as a possible mechanism by which illness-related cognitions and 
perceptions (i.e., illness-related stigma) may lead to negative psychosocial outcomes such as 
depression and anxiety. Theoretical models of illness intrusiveness posit that the intrusion of 
illness leads to negative psychosocial outcomes by reducing positive reinforcement from one’s 
environment and reducing one’s sense of control over their environment (Devins, 2010). 
Although illness intrusiveness may be partially driven by objective intrusions of illness into one’s 
abilities to engage in valued activities, the present analyses would suggest that illness 
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intrusiveness may be partially driven by negative cognitions, such as stigma, which result in an 
individual withdrawing from valued activities despite objective abilities to engage in these 
activities. Thus, illness intrusiveness may actually serve as a manifestation of stigma, as per 
Stevelink and colleagues’ (2012) model. With this model in mind, it may be that individuals who 
perceive and expect stigma might actually withdraw from valued activities in anticipation that 
their illness may be noticeable and negatively evaluated if they engage in these activities. In this 
manner, illness intrusiveness may serve as an important mechanism by which stigma leads to 
negative psychosocial outcomes.  
Clinical Implications 
The present study has multiple implications for potential systemic and clinical 
interventions. Most notably, the rates of depressive and anxious symptoms reported by AYAs in 
this sample were markedly elevated. Thus, there appears to be a great need for universities to 
provide appropriate screening and interventions to address psychosocial distress in college 
students with chronic illnesses, as they may be at particularly elevated risk for these negative 
psychosocial outcomes. Additionally, these results reveal multiple areas for intervention which 
may be helpful in addressing negative psychosocial outcomes. First, system-wide interventions 
aimed at reducing stigma are likely to be especially useful in alleviating perceptions of stigma in 
AYAs with chronic illnesses. Previous research has demonstrated that, with increased awareness 
about specific health conditions, perceptions of stigma are lowered (Vaughan & Hansen, 2004). 
As such, projects which aim to raise awareness about chronic illnesses on college campuses, or 
via social media may be especially useful in preventing or reducing perceptions of stigma across 
a large number of AYAs. Second, individual interventions which target distorted cognitions about 
illness-related cognitions, such as Cognitive Behavioral Therapy (CBT), or interventions which 
promote acceptance of things that cannot be changed, such as Acceptance and Commitment 
Therapy (ACT) may be useful in reducing perceived stigma and its effects on an individual level 
(Halliburton & Cooper, 2015; Hofman, 2013). Finally, interventions which target illness 
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intrusiveness, such as Behavioral Activation, may be particularly helpful in reducing negative 
psychosocial outcomes (McCauley et al., 2016).  
Future research is needed to test the applications of the aforementioned interventions in 
order to determine their efficacy in reducing stigma and its deleterious effects on mental health. 
Additional studies are also needed to replicate the present findings in other AYA samples. 
Further, given that AYAs with chronic illnesses have reduced social support as compared to their 
healthy peers, and that both stigma and illness intrusiveness are inherently social constructs, 
future research would benefit from the addition of social support to this model. Serial mediation 
could also be used to test additional models, as reductions in social support may be secondary to 
the observed intrusion of illness in this population, and reduction in social support may also help 
explain the occurrence of negative psychosocial outcomes.  
Limitations 
 The findings of the present study should be interpreted in light of a number of limitations. 
Most notably, the present study is cross-sectional in nature, which means that causality cannot be 
inferred from these analyses. Future research would benefit from the longitudinal analysis of 
these variables to better determine the temporal nature of these phenomena. Additionally, the 
present findings may have limited generalizability as the AYAs included in this sample were not 
particularly ethnically diverse and include disproportionately more females than males. 
Additionally, only AYAs enrolled in a university were included in the analyses, and thus these 
findings may not generalize to AYAs who did not go on to attend college. Finally, given the self-
report nature of the measures included, findings may be artificially bolstered by common method 
variance. However, in light of these limitations, the present study is believed to be an important 
contribution to our limited understanding of illness-related stigma in AYAs with a chronic illness.  
Conclusions 
 In sum, the present results validate previous findings that both illness-related stigma and 
illness intrusiveness are related to negative psychosocial outcomes (i.e., depressive and anxious 
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symptoms). Further, these findings are the first to examine this relationship in an AYA 
population. Additionally, these analyses revealed that illness intrusiveness may be a valuable 
mediator of the relationship between illness-related stigma and negative psychosocial outcomes. 
These findings have multiple implications for interventions to help alleviate negative 
psychosocial outcomes in AYAs with chronic illnesses, which may be particularly relevant for 
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Table 1. Demographic Characteristics (N = 285) 
Characteristic N (%) 
Ethnicity   
     Caucasian 222 (77.9) 
     African American 9 (3) 
     Hispanic 10 (3.5) 
     Native American 19 (6.7) 
     Asian 6 (2.1) 
     Multi-Racial 17 (6.0) 
     Not reported 2 (1) 
Age – Mean (SD) 20 (3.13) 
Sex  
     Female 218 (76.5) 
Grade Level   
     Freshman 143 (50.2) 
     Sophomore 67 (23.5) 
     Junior 37 (13) 
     Senior+ 38 (13.3)  
Chronic Medical Conditions Reported  
     Asthma 118 
     Gastrointestinal Disorders (i.e.,       
     Inflammatory Bowel Disease, Irritable 
     Bowel Syndrome) 
63  
     Type 1 Diabetes 19 
     Other (e.g., epilepsy, obesity, juvenile   
     rheumatoid arthritis) 
258 
 
Table 2. Average Total Scores and Standard Deviations 
Measures Mean SD Range 
SS 18.28 8.80  8-40  
II 34.74 17.48 13-84 
CES-D 20.58✝ 14.34 0-60 
SAS 42.14✝  11.24  21-76  
Note: SS = illness-related stigma, II = illness intrusiveness,  
CES-D= depressive symptoms scale, SAS = anxiety  
symptoms scale 






































Note: CES-D= depressive symptoms scale, SAS = anxiety symptoms  
scale, II = illness intrusiveness 


















Variables 1 2 3 4 
1. Stigma -       
2. II .63*** -   
3. CES-D .42*** .51*** -  
4. SAS .49***  .61***  .80***  - 
5. Severity .13* .18*** .02 .08 
6. Controllability -.21** -.26*** -.16** -.23*** 
7. Age .07  .11  -.03  .05  
8. Sex .07 .11 .06 .20** 
9. Ethnicity .02 .02 .09 .03 
10. Grade Level  .01  .10 -.12*  -.02 











Figure 2. Path Analysis Model.  
Note. Demographic variables (i.e., age, sex, ethnicity, education level) were controlled for  
in the model, but are not depicted. 
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